Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells

doi:10.4254/wjh.v12.i11.965

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5987)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

358

WORD

137

HTML

3053

Figures (1-6)

327

Sum=3875

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

639

Download

1473

Sum=2112

Nov 27, 2020 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Nov 27, 2020; 12(11): 965-975
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.965

Full Size Figure Download Figure

Figure 5 Anti-fibrotic effects of obeticholic acid on hepatic stellate cells activated by engulfment of apoptotic Huh7. 5-CYP cells. A: Col1A1 mRNA; B: Transforming growth factor-β mRNA. All data were obtained from 3 independent experiments and presented as mean ± SEM. Bars with different letters are significantly different at P ≤ 0.05. TGF: Transforming growth factor; HIV: Human immunodeficiency virus; OCA: Obeticholic acid.

Citation: New-Aaron M, Ganesan M, Dagur RS, Kharbanda KK, Poluektova LY, Osna NA. Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells. World J Hepatol 2020; 12(11): 965-975
URL: https://www.wjgnet.com/1948-5182/full/v12/i11/965.htm
DOI: https://dx.doi.org/10.4254/wjh.v12.i11.965